文献速递心外重症与机械循环支持

组蛋白修饰与非缺血性扩张型心肌病左室逆重构相关

Histone Modification Is Correlated With Reverse Left Ventricular Remodeling in Nonischemic Dilated Cardiomyopathy.
PubMed 文献 · Ann Thorac Surg · 2017-07-29

本研究纳入14例终末期非缺血性扩张型心肌病(DCM)患者,在植入左心室辅助装置(LVAD)并后续心脏移植后评估左室组蛋白修饰谱与血流动力学变化。LVAD支持2.5±1.2年后,左室功能显著逆重构伴心肌细胞尺寸减小,组蛋白甲基化相关分子表达被部分逆转,且ANP/BNP表达与H3K9me2和H3K9me3负相关。

要点

  • LVAD支持可部分逆转终末期非缺血性DCM左室的组蛋白甲基化表观遗传状态。
  • 逆重构伴随心肌细胞尺寸减小及ANP/BNP表达与H3K9me2/me3负相关。
  • 表观遗传调控可能是LVAD诱导左室逆重构的上游机制之一。

核心结论

  • 终末期非缺血性DCM患者心肌细胞组蛋白甲基化表观遗传状态发生显著改变,LVAD支持可部分逆转该状态及其上游信号,并与病理和功能逆重构相关。

研究设计与样本

  • 研究纳入14例终末期非缺血性DCM患者,均在本机构接受LVAD植入及后续心脏移植,并以3例不同正常左室样本作为对照。

主要发现

  • LVAD支持2.5±1.2年后,研究队列显示左室功能显著逆重构,伴左室组织病理学改变如心肌细胞尺寸减小。
  • 与正常左室相比,队列左室组织学表达较少的3种组蛋白甲基化相关分子(如H3K4me3、H3K9me2和H3K9me3),LVAD支持逆转了这些分子的表达。
  • LVAD支持的左室中,H3K9甲基转移酶和SUV39H1上调,而H3K9去甲基酶和JMJDs下调。
  • ANP和BNP的表达与H3K9me2和H3K9me3的表达呈负相关。

临床怎么用

  • 对于终末期非缺血性DCM患者,LVAD支持可能通过调节组蛋白甲基化状态促进左室逆重构,提示表观遗传通路可作为潜在干预靶点。

局限性

  • 样本量小(14例患者和3例对照),且为单中心研究,结论需更大规模研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although implantation of a left ventricular assist device (LVAD) induces reverse remodeling of the left ventricle in end-stage nonischemic dilated cardiomyopathy (DCM), the underlying mechanism is not fully understood. It has been shown that epigenetic modification, such as methylation or acetylation of the histone, is one of the most important upstream signals in cardiac failure. This study hypothesized that histone profiles may be modified by LVAD implantation for end-stage nonischemic DCM, in association with reverse left ventricular remodeling. METHODS: Hemodynamic changes associated with histone modification profiles in the left ventricle were comprehensively assessed in 14 patients with a diagnosis of end-stage nonischemic DCM. These patients underwent LVAD implantation and subsequent cardiac transplantation in our institution (Osaka University Hospital, Osaka, Japan). Samples of normal left ventricle from 3 different people were used as a control. RESULTS: After LVAD support for 2.5 ± 1.2 years, the study cohort showed a significant reverse remodeling of left ventricular function associated with histopathologic changes in the left ventricle, such as reduction of myocyte size. Although the left ventricle of the cohort histologically expressed less 3 histone methylation-related molecules (eg, H3 lysine 4 trimethylation [H3K4me3], H3 lysine 9 dimethylation [H3K9me2], and H3 lysine 9 trimethylation [H3K9me3]) compared with normal left ventricle, LVAD support reversed expression of these molecules, associated with up-regulation of H3 lysine 9 [H3K9] methyltransferase and suppressor of variegation 3-9 homologue 1 [SUV39H1] and with down-regulation of H3K9 demethylase and jumonji domains [JMJDs] in the LVAD-supported left ventricle. Moreover, expression of atrial natriuretic peptide and brain natriuretic peptide (ANP and BNP) was negatively correlated with that of H3K9me2 and H3K9me3. CONCLUSIONS: The epigenetic state of cardiac myocytes (eg, as histone methylation) was substantially modulated in end-stage nonischemic DCM. LVAD support partially reversed the epigenetic state and its upstream signals, in association with pathologic and functional reverse remodeling.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Ito E, Miyagawa S, Fukushima S, et al. Histone Modification Is Correlated With Reverse Left Ventricular Remodeling in Nonischemic Dilated Cardiomyopathy. Ann Thorac Surg. 2017. PMID: 28760462. doi:10.1016/j.athoracsur.2017.04.046

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。